FFCP PHASE1:Hg19::chr15:89787185..89787263,+
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p1@FANCI |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_FANCI_5end |
Coexpression cluster: | C109_Reticulocytes_non_acute_Hodgkin_Burkitt_retinoblastoma_lymphoma |
Association with transcript: | 0bp_to_ENST00000310775, ENST00000447611, ENST00000451393, NM_001113378, NM_018193, uc002bnm.1, uc002bnn.1, uc002bno.2, uc010bnp.1_5end |
EntrezGene: | FANCI |
HGNC: | 25568 |
UniProt: | Q9NVI1F8W7R3B3KNW8 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p1@FANCI |
---|
0
25
50
75
100
125
150
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 5.19e-59 | 235 |
disease of cellular proliferation | 1.48e-57 | 239 |
cell type cancer | 4.50e-30 | 143 |
organ system cancer | 2.05e-28 | 137 |
carcinoma | 4.34e-24 | 106 |
hematologic cancer | 1.73e-21 | 51 |
immune system cancer | 1.73e-21 | 51 |
leukemia | 3.29e-18 | 39 |
myeloid leukemia | 1.66e-13 | 31 |
Showing 1 to 9 of 9 entries